Rankings
▼
Calendar
BDSX FY 2025 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
FY 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$88M
+24.1% YoY
Gross Profit
$67M
75.2% margin
Operating Income
-$28M
-31.5% margin
Net Income
-$35M
-39.8% margin
EPS (Diluted)
$-4.67
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$24M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$87M
Total Liabilities
$90M
Stockholders' Equity
-$2M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$88M
$71M
+24.1%
Gross Profit
$67M
$56M
+19.5%
Operating Income
-$28M
-$34M
+19.2%
Net Income
-$35M
-$43M
+17.9%
← Q4 2024
All Quarters
Q1 2025 →